Generic Warfarin Recall Issued Due to Oversized Pills
Zydus Pharmaceuticals is recalling some of its generic warfarin blood thinner pills because they may be the wrong size, which could cause patients to suffer excessive bleeding and other potentially life-threatening health problems.
The generic warfarin recall was announced by the FDA on June 10, after Zydus received a complaint about pills from one lot, which turned out to be oversized.
Oversized warfarin pills could cause users to face increased blood thinning effects that put them at danger of severe bleeding problems. Although there have been no reports of adverse bleeding events linked to the recalled warfarin pills, the manufacturer is urging patients to make sure that all tablets are the same size.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The pills affected by the recall include warfarin 2 mg tablets with a lot number of MM5767 and an expiration date of June 2014. They have an NDC number of #6838205310 and were distributed in the United States from November 2012 to December 2012.
Warfarin has been sold for decades in the United States, most commonly known by the brand name Coumadin. The anticoagulant medication is used for prevention of thromboembolic complications, such as pulmonary embolism, and problems with atrial fibrillation and the prevention of strokes. It dominated the market until 2010, when a new generation of blood thinners like Pradaxa and Xarelto began to hit the market.
While this new class of medications has grown in popularity because they are easier to take, requiring less frequent monitoring during treatment to maintain therapeutic levels, concerns about arose about the potential risk of severe bleeding problems with Pradaxa. Unlike the anticoagulant effects of warfarin, which doctors can easily reverse with a dose of vitamin K, there is no reversal agent available for Pradaxa and Xarelto, which have resulted in many reports of uncontrollable bleeding that doctors were helpless to stop.
A growing number of Pradaxa lawsuits have been filed against Boehringer Ingelheim, alleging that the drug maker failed to adequately warn doctors and patients about the risks of Pradaxa bleeding.
brendaJanuary 2, 2018 at 6:26 pm
my sister passed at 45 years old,she was on this blood thinners 8 years it was listed on autopsy,has this drug caused deaths,could this be a reason she left us so soon she was on 6 mg sometimes 10mg 2 mg pillswas used also,she passed may 11 2017 weekly checkd was done on level,but this was list on autopsy.would like a attorney to look over.
"*" indicates required fields
More Top Stories
A federal judge has approved a plan appointing several dozen plaintiffs' attorneys to leadership positions in Bard Port Catheter litigation.
A ProPublica report reveals that Philips officials hid thousands of reports of problems with sound abatement foam used in millions of CPAP machines, failing to recall the devices for more than a decade after receiving the first complaints.
A Suboxone lawsuit claims the opioid addiction treatment's dental side effects can lead to severe tooth damage and decay.